- Home
- MHH vs RPTX Comparison
MHH vs RPTX Comparison
Compare MHH & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHH
- RPTX
- Stock Information
- Founded
- MHH 1986
- RPTX 2016
- Country
- MHH United States
- RPTX Canada
- Employees
- MHH N/A
- RPTX N/A
- Industry
- MHH Professional Services
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- MHH Consumer Discretionary
- RPTX Health Care
- Exchange
- MHH Nasdaq
- RPTX Nasdaq
- Market Cap
- MHH 86.6M
- RPTX 72.6M
- IPO Year
- MHH N/A
- RPTX 2020
- Fundamental
- Price
- MHH $7.35
- RPTX $1.82
- Analyst Decision
- MHH
- RPTX Strong Buy
- Analyst Count
- MHH 0
- RPTX 3
- Target Price
- MHH N/A
- RPTX $4.50
- AVG Volume (30 Days)
- MHH 10.8K
- RPTX 98.0K
- Earning Date
- MHH 11-05-2025
- RPTX 11-06-2025
- Dividend Yield
- MHH N/A
- RPTX N/A
- EPS Growth
- MHH N/A
- RPTX N/A
- EPS
- MHH 0.07
- RPTX N/A
- Revenue
- MHH $200,000,000.00
- RPTX $250,000.00
- Revenue This Year
- MHH N/A
- RPTX N/A
- Revenue Next Year
- MHH $3.78
- RPTX N/A
- P/E Ratio
- MHH $99.56
- RPTX N/A
- Revenue Growth
- MHH 5.16
- RPTX N/A
- 52 Week Low
- MHH $6.20
- RPTX $0.89
- 52 Week High
- MHH $16.00
- RPTX $4.07
- Technical
- Relative Strength Index (RSI)
- MHH 41.74
- RPTX 60.62
- Support Level
- MHH $7.48
- RPTX $1.67
- Resistance Level
- MHH $7.75
- RPTX $1.85
- Average True Range (ATR)
- MHH 0.29
- RPTX 0.06
- MACD
- MHH -0.05
- RPTX 0.00
- Stochastic Oscillator
- MHH 5.17
- RPTX 78.38
About MHH Mastech Digital Inc
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.